Søgning
Søgning på udtrykket 'borrelia' giver 20 resultater
Dokumenter [2]
Sider [2]
Nyt fra tidsskrifterne [16]
Klinik, diagnostik og behandling af Lyme Borreliose i Danmark.
Forfattergruppen er nedsat af Dansk Selskab for Klinisk Mikrobiologi, Dansk Selskab for Infektionsmedicin og Dansk Neurologisk Selskab.
Denne vejledning er tiltænkt diagnostik og behandling af formodet Lyme neuroborreliose hos voksne. Vejledningen er udarbejdet som et supplement til Borrelia klaringsrapport (2014).
fter godkendelse.,
At orientere DSI's bestyrelse ved nye medlemmer i gruppen, eller hvis medlemmer udgår efter ønske eller ved inaktivitet.,
Nedenfor vises selskabets repræsentanter i diverse arbejdsgrupper, og publicerede guidelines.
Borrelia:
Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson
Borrelia klaringsrapport (2014),
Diagnostik og behandling af Lyme neuroborreliose (2021),
COVI
r modic-forandringer, og skal de behandles? / Gruppe 2.
15.00-15.15 Kaffepause.
15.15-15.35 Akut monoartrit. Hvilket udredningsprogram vil I foreslå? / Gruppe 4.
15.35-15.55 Opsamling til patienten, der præsenterer sig med feber og ledsymptomer: borrelia, gonore, TB / Pernille Ravn.
15.55-16.15 Flytte til andet lokale.
16.15-17.30 Patientcase / Gruppearbejde/plenum.
19.00 Middag arrangeret af kursister.
.
Onsdag d. 28. oktober 2015, kl. 08.30-16.15.
08.30-08.45 Hvad lærte vi i går
Nyt fra tidsskrifterne [16]
Infection and Immunity
13.11.2024
Infection and Immunity, Ahead of Print.
Clinical Microbiology and Infection
23.10.2024
We have developed targeted proteomics in the context of Lyme borreliosis as a new direct diagnostic tool for detecting Borrelia proteins in the skin of patients with erythema migrans. If satisfactory, this proteomic technique could be used in addition to culture and/or PCR for disseminated infections, where Borrelia detection is essential to demonstrate active infection. In these infections, diagnosis is indirect and relies mainly on serology.
Emerg Microbes Infect
12.10.2024
Volume 13, Issue 1, December 2024 .
Infection
2.10.2024
. Abstract. . Background. Lyme borreliosis is one of the most prevalent tick-borne diseases in Europe. Studies on seroprevalence of Borrelia burgdorferi IgG antibodies in children are rare. The aim of this study was to determine the seroprevalence of B. burgdorferi IgG antibodies in children and adolescents residing in North-Western Switzerland and neighbouring countries. . . .
Trends in Microbiology
28.09.2024
Borrelia (Borreliella) burgdorferi is a bacterial pathogen transmitted by hard ticks of the genus Ixodes; it circulates in nature, through an enzootic cycle, between the ticks and a range of vertebrates that act as reservoirs. It is the causative agent of Lyme disease (LD)/Lyme borreliosis in humans, which is the fastest expanding vector-borne disease in the Northern Hemisphere. Borrelia spirochetes are flat wave in appearance with an undulating cell morphology. B. burgdorferi has a bundle of 7–11 helical
Infection and Immunity
10.08.2024
Infection and Immunity, Ahead of Print.
Infection
10.07.2024
Abstract. . Purpose. Diagnosis of (European) Lyme neuroborreliosis has been based on clinical presentation, cerebrospinal fluid (CSF) pleocytosis and demonstration of intrathecal borrelial antibody synthesis (ITBAS) to document Borrelia burgdorferi s. l. infection. It is not known if other criteria to document Borrelia infection may contribute to the diagnosis. . . . Methods.
BMJ Open
11.06.2024
. Introduction. Ixodes ticks are pivotal in transmitting diseases like Lyme disease and human granulocytic anaplasmosis, caused by Borrelia burgdorferi and Anaplasma phagocytophilum, respectively. These pathogens not only affect humans through single or multiple tick bites but also pose risks to animal hosts, leading to potential coinfections. Despite regional studies indicating significant prevalence, their global coinfection data remain sparse. This study aims to bridge this gap through a systematic rev
Lancet Microbe
16.05.2024
The predicted high-risk regions are considerably larger than in previous reports. Identification, surveillance, and diagnosis of RFGB infections should be prioritised in high-risk areas, especially within low-income regions.
Infection and Immunity
4.05.2024
Infection and Immunity, Ahead of Print.
Infection and Immunity
22.03.2024
Infection and Immunity, Ahead of Print.
Clinical Microbiology and Infection
3.02.2024
To investigate the short- and long-term risks of atrioventricular block and other cardiac conduction disorders associated with being tested for Borrelia burgdorferi (Bb) antibodies or Bb seropositivity as measures of confounding by indication and Bb infection, respectively.
Infection and Immunity
16.12.2023
Infection and Immunity, Ahead of Print.
Infection
4.12.2024
ctivity/therapeutic efficacy in the context of Lyme neuroborreliosis (LNB). . . . Methods. A prospective dual-centre study was conducted from 05/14 − 01/18. With respect to Borrelia-LTT a comparison was made between patients suffering from confirmed acute LNB and patients being affected by inflammatory neurologic diseases, defining the control group: Bell‘s palsy, viral meningitis, herpes zoster, Guillain-Barré-Syndrome an
International Journal of Infectious Diseases
20.09.2024
Lyme borreliosis (LB), an infection caused by the spirochete Borrelia burgdorferi sensu lato complex (Bbsl), is the most common tick-borne disease in Europe [1]. Although LB commonly presents as erythema migrans (EM), Bbsl infection can disseminate resulting in Lyme neuroborreliosis (LNB), arthritis, or carditis [1].
BMC Infectious Diseases
22.03.2024
Methods. We performed genome-wide association studies in a prospective cohort of 1138 patients with physician-confirmed Lyme borreliosis (LB), the most common tick-borne disease in the Northern hemisphere caused by the bacterium Borrelia burgdorferi sensu lato. Genome-wide variants in LB patients—divided into a discovery and validation cohort—were compared to two healthy cohorts. Additionally, ex vivo monocyte-derived cytokine responses of peripheral blood mononuclear cells to